C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/395 (2006.01) A61K 31/41 (2006.01) A61K 31/4188 (2006.01) A61K 31/7052 (2006.01) A61P 31/12 (2006.01) C07H 19/23 (2006.01)
Patent
CA 2722084
Provided are imidazol [1,5-f] [1,2.4]triazinyl, imidazol [1,2,4]triazinyl, and [1,2,4] triazolo [4,3-f] [1,2,4] triazinyl nucleosides of formula I nucleoside phosphates and prodrugs thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections. Wherein X1 or X2 is indepently C-R10 or N and wherein at least one of X1 or X2 is N.
L'invention porte sur des imidazol [1,5-f] [1,2,4]triazinyl, imidazol [1,2,4]triazinyl, et [1,2,4] triazolo [4,3-f] [1,2,4] triazinyl nucléosides de formule I1, sur des nucléosides phosphates et promédicaments de ceux-ci. Les composés, compositions et procédés sont utiles pour le traitement d'infections par un virus de la famille Flaviviridae, en particulier des infections de l'hépatite C. Dans la formule, X1 ou X2 est indépendamment C-R10 ou N et au moins l'un de X1 ou X2 est N.
Cho Aesop
Kim Choung U.
Parrish Jay
Xu Jie
Gilead Sciences Inc.
Robic
LandOfFree
Carba-nucleoside analogs for antiviral treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carba-nucleoside analogs for antiviral treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carba-nucleoside analogs for antiviral treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1723815